Recombinant Sordaria macrospora Formation of crista junctions protein 1 (FCJ1)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Sordaria macrospora Formation of Crista Junctions Protein 1 (FCJ1)

Recombinant Sordaria macrospora Formation of crista junctions protein 1 (FCJ1) is a recombinant protein derived from the fungus Sordaria macrospora. This protein is crucial for the formation of crista junctions (CJs) in mitochondria, which are essential for maintaining mitochondrial architecture and function. Crista junctions are tubular invaginations of the inner mitochondrial membrane that connect the inner boundary with the cristae membrane, playing a vital role in mitochondrial organization and energy production .

Structure and Function of FCJ1

FCJ1, also known as mitofilin in mammals, is specifically enriched in crista junctions. It is anchored to the inner mitochondrial membrane by a single N-terminal transmembrane segment, exposing the major part of the protein to the intermembrane space . The C-terminal domain of FCJ1 is highly conserved and essential for its function, particularly in forming oligomers and interacting with the TOB/SAM complex, which is involved in the insertion of β-barrel proteins into the outer mitochondrial membrane .

Key Features of FCJ1:

  • Species: Sordaria macrospora

  • Protein Type: Recombinant

  • Function: Essential for crista junction formation and mitochondrial architecture

  • Expression System: Produced in E. coli in vitro expression system

Research Findings on FCJ1

Research on FCJ1 has highlighted its critical role in mitochondrial structure and function. Cells lacking FCJ1 exhibit defects in crista junction formation, leading to irregular mitochondrial morphology and altered cristae structure . Overexpression of FCJ1 results in increased crista junction formation and branching of cristae .

Impact of FCJ1 on Mitochondrial Structure:

ConditionMitochondrial Phenotype
FCJ1 DeletionLack of CJs, concentric stacks of inner membrane
FCJ1 OverexpressionIncreased CJ formation, branching of cristae

Production and Availability of Recombinant FCJ1

Recombinant FCJ1 is available for research purposes, produced in E. coli expression systems. It is offered in various sizes, with a typical product size of 50 μg . The protein is stored in a Tris-based buffer with 50% glycerol and should be kept at -20°C for long-term storage .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Consult your local distributor for precise delivery estimates.
Note: Shipping is standard with blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, which can be used as a reference.
Shelf Life
Shelf life depends on several factors including storage conditions, buffer composition, temperature, and the protein's inherent stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during the production process. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
MIC60; SMAC_01581; MICOS complex subunit MIC60; Mitofilin
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
42-684
Protein Length
Full Length of Mature Protein
Species
Sordaria macrospora (strain ATCC MYA-333 / DSM 997 / K(L3346) / K-hell)
Target Names
MIC60
Target Protein Sequence
ADDKKPVVPEPAQPAVLPASETLTAPSTPPPASPQVEPTSTIAPETTPLTPPAPEATVIP PVAEEPVVPPTLPTPRKKKGFFRRLRNFLLSLTILGAIAFGGGVYYSRINDAFHDFFTEY IPYGEQAVLYLEELDFKKRFPDVVSRVTGRPRDSGEQVKVPAQSGASWRVADGGEPAGRQ SSSIKKAAVAAKDAVTKSEPAVVAGANKDTAELPKAESTTTVTPVEPVPVAVAVADPATA VAPADTAAAAAPAKKPFKAPEVDEPSRWPPASPIDPLKVNGATDPIVQDLVHMLNDIITV INHDNANEKYAPTIGKAKNELSKVAGRINEMKAKVEAEASKQVKARVDGFDKAANELVSR VESAMAAQEAAWRREFEEEMIRLKKSYDEKIHLIQDRERQIAEEKLNNRLLEQAIQLQRQ FTDDIKKHVEEERDGRLGKLNELSSAVADLEKLTSGWNEVVDTNLRTQQLHVAVEAVRAS LQDAHHPRPFIKELVALKEIAAEDPVVDAAISSINPTAYQRGISTSAELIDRFRRVATEV RKASLLPEDAGVASHASSYVLSKLMFKKEGLAAGDDVESILTRTQTYLEEGDLDNAAREI NGLQGWAKTLSRDWLGEVRKVLEVQQALEVIQTEARLQSLRME
Uniprot No.

Target Background

Function

Recombinant Sordaria macrospora Formation of Crista Junctions protein 1 (FCJ1) is a component of the Mitochondrial Contact Site and Cristae Organizing System (MICOS) complex. This large protein complex, located within the mitochondrial inner membrane, plays critical roles in maintaining crista junctions, preserving inner membrane architecture, and forming contact sites with the outer membrane. FCJ1 contributes to the structural integrity of cristae membranes by connecting them to the inner boundary membrane and facilitates protein import via the mitochondrial intermembrane space assembly (MIA) pathway.

Database Links
Protein Families
MICOS complex subunit Mic60 family
Subcellular Location
Mitochondrion inner membrane; Single-pass membrane protein.

Q&A

What is FCJ1 protein and what is its significance in mitochondrial research?

FCJ1 (Formation of Crista Junctions protein 1) is a mitochondrial inner membrane protein that is preferentially located at crista junctions (CJs) and is crucial for their formation. CJs are tubular invaginations of the inner membrane that connect the inner boundary with the cristae membrane, representing critical architectural elements for mitochondrial function. The protein is also known as MIC60 or SMAC_015 in Sordaria macrospora. FCJ1's significance lies in its essential role in maintaining mitochondrial architecture, which directly impacts cellular respiration and energy production .

How does the structure of S. macrospora FCJ1 compare to its homologs in other organisms?

S. macrospora FCJ1 shares structural features with its homologs across species, including yeast Fcj1 and mammalian mitofilin. The full-length mature protein (amino acids 42-684) contains highly conserved domains, particularly in the C-terminal region, which is the most functionally significant part of the protein. The N-terminal region contains a mitochondrial targeting sequence, followed by a transmembrane domain that anchors the protein to the inner mitochondrial membrane. The specific variations in sequence between species reflect evolutionary adaptations while maintaining the core functional domains that are essential for crista junction formation .

What are the specific domains of FCJ1 and their functional significance?

FCJ1 contains several key domains with distinct functions:

DomainPositionFunction
N-terminalN-terminusContains mitochondrial targeting sequence
TransmembraneNear N-terminusAnchors protein to inner mitochondrial membrane
Coiled-coilMiddle regionInvolved in protein-protein interactions
C-terminalC-terminusMost conserved; essential for FCJ1 function and oligomerization; interacts with TOB/SAM complex

The C-terminal domain is particularly critical - in its absence, formation of crista junctions is strongly impaired, resulting in irregular and stacked cristae. This domain mediates interactions with full-length FCJ1 (suggesting a role in oligomer formation) and with the TOB/SAM complex, which is required for the insertion of β-barrel proteins into the outer membrane .

What expression systems are effective for producing recombinant S. macrospora FCJ1?

E. coli expression systems have been successfully employed to produce recombinant S. macrospora FCJ1. Specifically, the full-length mature protein (amino acids 42-684) can be expressed with an N-terminal His-tag to facilitate purification. This approach allows for high-yield production of functional protein suitable for structural and biochemical studies. When designing expression constructs, researchers should consider excluding the mitochondrial targeting sequence (typically the first 41 amino acids) as this can improve expression efficiency in bacterial systems .

The expression protocol typically involves:

  • Cloning the FCJ1 sequence (excluding signal peptide) into an expression vector with an N-terminal His-tag

  • Transforming into an appropriate E. coli strain (BL21 or similar)

  • Inducing expression under optimized conditions (temperature, IPTG concentration)

  • Harvesting and lysing cells followed by affinity purification using His-tag

How can researchers effectively study FCJ1 protein interactions with the TOB/SAM complex?

To study FCJ1 interactions with the TOB/SAM complex, researchers can employ multiple complementary approaches:

  • Co-immunoprecipitation (Co-IP): Using antibodies against FCJ1 or components of the TOB/SAM complex (particularly Tob55) to pull down protein complexes from mitochondrial extracts, followed by Western blotting to detect interacting partners.

  • Yeast two-hybrid (Y2H) assays: To identify direct protein-protein interactions between specific domains of FCJ1 (especially the C-terminal domain) and components of the TOB/SAM complex.

  • Biolayer interferometry or surface plasmon resonance: To quantitatively measure binding kinetics between purified recombinant FCJ1 and TOB/SAM components.

  • Proximity labeling methods: Using BioID or APEX2 fused to FCJ1 to identify proteins in close proximity in vivo.

  • Cryo-electron microscopy: To visualize the structural relationship between FCJ1 and the TOB/SAM complex at contact sites.

The critical aspect of these studies is to focus on the C-terminal domain of FCJ1, as it has been specifically implicated in the interaction with Tob55 of the TOB/SAM complex .

What techniques are most effective for visualizing crista junction formation and structure?

Several advanced microscopy and biochemical techniques can be employed for studying crista junction formation and structure:

TechniqueApplicationResolutionAdvantages
Transmission electron microscopy (TEM)Visualizing mitochondrial ultrastructure0.5-2 nmDirect visualization of CJs
Electron tomography3D reconstruction of mitochondrial membranes2-5 nmDetailed 3D structural information
Super-resolution microscopyLocalizing FCJ1 and associated proteins20-50 nmLive cell imaging possible
Correlative light and electron microscopy (CLEM)Combining protein localization with ultrastructureVariableLinks protein distribution to structure
Cryo-electron microscopyHigh-resolution structural analysisNear-atomicPreserves native protein states

For optimal results, researchers should combine imaging approaches with genetic manipulations (knockouts, mutations) of FCJ1 to correlate protein function with structural outcomes .

How does FCJ1 function differ between model organisms, and what are the implications for research?

FCJ1 function shows both conservation and divergence across model organisms:

In yeast (S. cerevisiae), Fcj1 is primarily involved in maintaining crista junction structure and stability. Its deletion leads to the absence of normal crista junctions and the appearance of stacked inner membrane structures.

In mammals, the homolog mitofilin/MIC60 has broader functions, including roles in protein import, mitochondrial DNA maintenance, and as a core component of the MICOS complex (Mitochondrial Contact Site and Cristae Organizing System).

In S. macrospora, FCJ1 appears to have functions similar to both yeast and mammalian homologs, making it an excellent model system for comparative studies. The protein (also known as MIC60 in S. macrospora) is associated with the inner mitochondrial membrane and is critical for crista junction formation .

These differences highlight the importance of selecting the appropriate model organism based on specific research questions. When studying basic crista junction formation mechanisms, yeast or S. macrospora may be preferred, while mammalian models might be more relevant for disease-related research.

What are the consequences of FCJ1 deletion or mutation on mitochondrial structure and function?

The deletion or mutation of FCJ1 has profound effects on mitochondrial architecture and function:

  • Structural alterations:

    • Absence of normal crista junctions

    • Formation of stacked, concentric cristae membranes

    • Irregular cristae morphology

    • Altered mitochondrial inner membrane topology

  • Functional consequences:

    • Impaired oxidative phosphorylation efficiency

    • Altered mitochondrial membrane potential

    • Disrupted coordination between inner and outer membranes

    • Compromised association of the TOB/SAM complex with contact sites

  • Cellular impacts:

    • Energy metabolism deficiencies

    • Potential activation of mitochondrial stress responses

    • Altered calcium homeostasis due to disrupted ER-mitochondria contacts

The severity of these effects can vary depending on the specific mutation, with C-terminal domain mutations typically causing the most significant defects due to this region's importance for protein-protein interactions and oligomerization .

How does FCJ1 coordinate with other mitochondrial membrane proteins to establish crista morphology?

FCJ1 coordinates with multiple protein complexes to establish proper crista morphology:

  • Interaction with the TOB/SAM complex: FCJ1, particularly its C-terminal domain, interacts with Tob55 of the TOB/SAM complex. This interaction stabilizes crista junctions in close proximity to the outer membrane, creating a physical link between inner and outer mitochondrial membranes.

  • Oligomerization: FCJ1 forms homo-oligomers through interactions involving its C-terminal domain, creating a structural scaffold that maintains the tubular morphology of crista junctions.

  • Coordination with cohesin-like proteins: Similar phenotypic defects in crista junction formation occur in the absence of FCJ1 and certain cohesin-related proteins, suggesting functional cooperation in maintaining mitochondrial membrane architecture.

  • Integration with membrane contact sites: FCJ1 likely participates in organizing specialized membrane contact sites between the inner and outer mitochondrial membranes, facilitating lipid transfer and communication between these membranes.

This complex network of interactions ensures proper mitochondrial membrane organization, which is essential for efficient oxidative phosphorylation and other mitochondrial functions .

What are optimal conditions for the storage and handling of recombinant FCJ1 protein?

For optimal stability and activity of recombinant S. macrospora FCJ1 protein:

  • Storage conditions:

    • Store lyophilized powder at -20°C/-80°C upon receipt

    • After reconstitution, store at -80°C in small aliquots to avoid repeated freeze-thaw cycles

    • For working aliquots, store at 4°C for up to one week

    • Addition of 5-50% glycerol (final concentration) is recommended for long-term storage

  • Reconstitution protocol:

    • Briefly centrifuge vial prior to opening

    • Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL

    • For optimal stability, add glycerol to a final concentration of 50%

  • Buffer considerations:

    • The protein is stable in Tris/PBS-based buffer, pH 8.0, containing 6% trehalose

    • When designing experiments, consider the potential effects of buffer components on protein activity

  • Handling precautions:

    • Avoid repeated freeze-thaw cycles as they can lead to protein denaturation

    • Work at appropriate temperatures (typically 4°C) during purification and experimental procedures

    • Consider the addition of protease inhibitors when working with cell or tissue extracts

What experimental approaches can demonstrate the functional significance of FCJ1's C-terminal domain?

To demonstrate the functional significance of FCJ1's C-terminal domain, researchers can implement several complementary approaches:

  • Domain deletion and mutation studies:

    • Generate truncated versions of FCJ1 lacking the C-terminal domain

    • Create point mutations in conserved residues within the C-terminal domain

    • Express these constructs in FCJ1-knockout cells and assess rescue of phenotype

  • Structure-function analysis:

    • Perform detailed structural characterization of the C-terminal domain using X-ray crystallography or NMR

    • Correlate structural features with functional outcomes in mutation studies

  • Protein interaction mapping:

    • Use pull-down assays with isolated C-terminal domain to identify interaction partners

    • Employ crosslinking mass spectrometry to map interaction surfaces between FCJ1 and binding partners like Tob55

    • Perform competition assays to determine if the isolated C-terminal domain can disrupt full-length FCJ1 interactions

  • In vivo imaging:

    • Use fluorescently tagged C-terminal domain constructs to observe localization

    • Implement FRET-based approaches to study real-time protein interactions

  • Electron microscopy:

    • Compare mitochondrial ultrastructure in cells expressing wild-type FCJ1 versus C-terminal domain mutants

    • Quantify changes in crista junction number, structure, and distribution

These approaches can collectively establish the critical role of the C-terminal domain in FCJ1 function, particularly in mediating protein-protein interactions and maintaining proper crista junction architecture .

How can researchers effectively study the interplay between FCJ1 and the TOB/SAM complex in crista junction formation?

To investigate the interplay between FCJ1 and the TOB/SAM complex in crista junction formation, researchers can employ a multifaceted approach:

  • Genetic manipulation strategies:

    • Generate single and double knockout/knockdown models of FCJ1 and TOB/SAM components

    • Create chimeric proteins or domain swaps to identify regions critical for functional interactions

    • Implement inducible expression systems to study temporal aspects of complex formation

  • Biochemical interaction analysis:

    • Perform reciprocal co-immunoprecipitation experiments

    • Use chemical crosslinking followed by mass spectrometry to map interaction interfaces

    • Implement blue native PAGE to identify native complexes containing both FCJ1 and TOB/SAM components

  • Advanced imaging techniques:

    • Apply correlative light and electron microscopy to simultaneously visualize protein localization and membrane ultrastructure

    • Use super-resolution microscopy to analyze co-localization patterns of FCJ1 and TOB/SAM components

    • Implement live-cell imaging to track dynamic interactions between these proteins

  • Functional assays:

    • Measure mitochondrial membrane potential in cells with manipulated FCJ1-TOB/SAM interactions

    • Assess respiratory capacity and metabolic function

    • Analyze mitochondrial dynamics and biogenesis

  • Quantitative analysis framework:

    • Develop quantification methods for crista junction number, size, and distribution

    • Implement computational modeling to predict structural outcomes of protein interactions

    • Establish correlation analyses between protein levels/interactions and structural phenotypes

This comprehensive approach would allow researchers to establish not only the physical interactions between FCJ1 and the TOB/SAM complex but also their functional significance in maintaining proper mitochondrial architecture .

What are promising approaches for therapeutic targeting of FCJ1-related mitochondrial dysfunction?

While direct therapeutic applications for FCJ1 modification are still emerging, several promising approaches warrant investigation:

  • Small molecule modulators:

    • Design compounds that stabilize FCJ1 oligomerization or interaction with the TOB/SAM complex

    • Develop molecules that can compensate for FCJ1 dysfunction by promoting alternative cristae stabilization mechanisms

    • Screen for compounds that enhance remaining FCJ1 function in partial loss-of-function scenarios

  • Gene therapy approaches:

    • Explore viral vector delivery of functional FCJ1 to tissues with mitochondrial dysfunction

    • Investigate CRISPR-based approaches for correcting FCJ1 mutations

    • Develop RNA-based therapeutics to modulate FCJ1 expression levels

  • Mitochondrial transplantation:

    • Investigate the potential for delivery of functional mitochondria with normal FCJ1 expression to cells with compromised mitochondrial function

    • Explore tissue-specific targeting strategies for mitochondrial transplantation

  • Metabolic bypass strategies:

    • Identify and target metabolic pathways that can compensate for energy production deficits resulting from abnormal cristae structure

    • Develop approaches to enhance alternative energy production pathways in cells with FCJ1 dysfunction

  • Protein replacement therapy:

    • Investigate mitochondrial-targeted delivery of recombinant FCJ1 protein using specialized delivery systems

    • Develop modified versions of FCJ1 with enhanced stability or function for therapeutic applications

These approaches represent potential translational directions for basic research on FCJ1 function and could ultimately lead to treatments for mitochondrial disorders associated with crista junction abnormalities .

How might systems biology approaches enhance our understanding of FCJ1's role in mitochondrial networks?

Systems biology approaches offer powerful frameworks for understanding FCJ1's role within the broader context of mitochondrial networks:

  • Multi-omics integration:

    • Combine proteomics, transcriptomics, and metabolomics data from FCJ1 mutant/knockout models

    • Develop integrated network models that link FCJ1 status to downstream cellular consequences

    • Identify metabolic signatures associated with FCJ1 dysfunction that could serve as biomarkers

  • Mathematical modeling of mitochondrial architecture:

    • Develop computational models of cristae formation incorporating FCJ1's mechanical and biochemical properties

    • Simulate the effects of FCJ1 alterations on mitochondrial membrane dynamics and energy production

    • Create predictive models linking crista junction structure to functional outcomes

  • Network analysis of protein interactions:

    • Map the complete interactome of FCJ1 across different cellular conditions

    • Identify regulatory hubs and feedback mechanisms in the network

    • Predict synthetic interactions that could modulate FCJ1 function

  • Evolutionary systems biology:

    • Compare FCJ1 functions across species to identify fundamental versus specialized roles

    • Reconstruct the evolutionary history of mitochondrial architecture regulation

    • Identify conserved network motifs in crista junction maintenance

  • Single-cell approaches:

    • Analyze cell-to-cell variability in FCJ1 expression and mitochondrial morphology

    • Investigate the potential for compensatory mechanisms at the single-cell level

    • Develop single-cell resolution maps of mitochondrial network states

These systems-level approaches would allow researchers to move beyond reductionist views of FCJ1 function and understand how it operates within the complex, dynamic system of mitochondrial regulation .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.